Assessment of rasagiline as add-on therapy to levodopa for selected motor and non-motor symptoms in Parkinson's disease
American Journal of Translational Research · 2026 · 18 (10) · 9185-9195
DOI: 10.62347/ortj1683 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Translational Research, 2026. Verfasst von Jingya Sun und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sun, J., Tong, D., Zhou, S., Wei, M., Yu, G., Liu, C., & Gao, X. (2026). Assessment of rasagiline as add-on therapy to levodopa for selected motor and non-motor symptoms in Parkinson's disease. American Journal of Translational Research, 18(10), 9185-9195. https://doi.org/10.62347/ortj1683
Vancouver
Sun J, Tong D, Zhou S, Wei M, Yu G, Liu C, et al. Assessment of rasagiline as add-on therapy to levodopa for selected motor and non-motor symptoms in Parkinson's disease. American Journal of Translational Research. 2026;18(10):9185-9195. doi:10.62347/ortj1683
BibTeX
@article{Sun2026,
author = {Sun, Jingya and Tong, Dapeng and Zhou, Shuoyan and Wei, Mingzhuo and Yu, Ge and Liu, Chen and Gao, Xin},
title = {Assessment of rasagiline as add-on therapy to levodopa for selected motor and non-motor symptoms in Parkinson's disease},
journal = {American Journal of Translational Research},
year = {2026},
volume = {18},
number = {10},
pages = {9185--9195},
doi = {10.62347/ortj1683}
}
EUVIMED